A specialist animal health company,built on patent.
Manoira commercialises a patent-backed portfolio in stable, solid-form cannabinoids for animal and pet health.
Innovative products for the optimised treatment of companion animals and livestock.
Manoira specialises in the development of innovative products for the optimised treatment of companion animals and livestock, developed in-house or sublicensed from leading pharmaceutical partners. Its pipeline targets pain, inflammation, nausea, and anxiety, featuring patented cocrystal forms of cannabinoids with enhanced thermal stability for species-specific applications.
Backed by a 20-year solid-form patent, Manoira holds a strong intellectual property position and a sustainable competitive edge in the animal health sector.
Prototype products coming soon.
First prototype formulations across the dog, cat and equine ranges are in late-stage development and will be unveiled in the months ahead.